Decentralized Clinical Research to Reduce Health Inequities.

The problem that Tury Health is working to solve is the lack of inclusivity and diversity in clinical trials. Currently, clinical trials are predominantly conducted on a small, homogenous group of individuals, which can limit the generalizability of the results and exclude underrepresented populations from accessing life-saving treatments and therapies.

The lack of diversity in clinical trials is a global problem that affects millions of people worldwide. In the United States, for example, racial and ethnic minorities are significantly underrepresented in clinical trials, despite being disproportionately affected by many health conditions. According to a report by the FDA, African Americans and Hispanics make up only 5% and 1% of clinical trial participants, respectively, despite representing 13% and 18% of the US population.

This lack of diversity can have significant implications for the accuracy and effectiveness of clinical trial results. For example, certain medications may have different efficacy or side effects in different populations, and a lack of diversity in clinical trials can lead to the under or over-representation of certain groups, which can skew results.

Tury Health's decentralized clinical trial platform aims to address this problem by automating and streamlining the recruitment process and making clinical trials more accessible to a diverse range of participants. By leveraging advanced AI algorithms and blockchain technology, Tury Health can help clinical trial sponsors recruit a more diverse range of participants, including individuals from underrepresented communities, and increase the generalizability and accuracy of study results.

Furthermore, Tury Health's suite of AI-powered solutions can help healthcare providers overcome other barriers to diversity and inclusivity in healthcare, such as language barriers, lack of transportation, and other social determinants of health. By automating administrative tasks and streamlining healthcare workflows, Tury Health's solutions can help healthcare providers focus on delivering patient-centered care and addressing the unique needs of diverse patient populations.

The scale of the lack of diversity in clinical trials is significant, with millions of people worldwide being affected. By improving the inclusivity and diversity of clinical trials, Tury Health's technology has the potential to improve patient outcomes and increase access to life-saving treatments and therapies for underrepresented populations.

In addition to the lack of diversity in clinical trials, Tury Health is also working to address other challenges within the healthcare industry, such as the high cost of healthcare, administrative inefficiencies, and the growing burden of chronic disease. By leveraging cutting-edge technology and a patient-centered approach, Tury Health is committed to driving innovation and improving the healthcare industry for everyone.

Tury Health is a healthcare technology startup leveraging advanced AI and blockchain technology to revolutionize the healthcare industry. Our comprehensive healthcare technology ecosystem includes a decentralized clinical trial platform, patient enrollment, remote patient monitoring, virtual lab, and a suite of AI-powered solutions that help healthcare providers streamline workflows and automate administrative tasks.

Our decentralized clinical trial platform connects clinical trial sponsors with potential participants by using AI algorithms to analyze and match potential participants based on various criteria. It also utilizes blockchain technology to ensure participant data security and privacy.

One of our key advantages is increasing the inclusivity and diversity of clinical trials. By automating the recruitment process, our platform makes it more accessible to a diverse range of participants, including underrepresented communities.

In addition, our suite of AI-powered solutions, including patient triage, medical imaging analysis, and predictive analytics tools, helps healthcare providers deliver more personalized and efficient care to their patients.

Our business model generates revenue by selling our platform and solutions to healthcare organizations, clinical research organizations, and pharmaceutical companies. We seek investment to accelerate development, expand our team, and increase marketing efforts.

We are dedicated to driving innovation and improving the healthcare industry. Our experienced team and innovative technology put us in a strong position to make a meaningful impact on the lives of patients worldwide.

Tury Health's solution serves a diverse range of stakeholders within the healthcare industry, including clinical trial sponsors, pharmaceutical companies, medical device companies, and digital health startups seeking to validate their products using rigorous and regulatory-grade scientific research.

One of the key target populations that Tury Health is working to address is underserved communities that have historically been excluded from clinical trials. By increasing the inclusivity and diversity of clinical trials, we can ensure that patients from all backgrounds have access to life-saving treatments and therapies that may otherwise have been unavailable to them.

According to a report by the FDA, African Americans and Hispanics make up only 5% and 1% of clinical trial participants, respectively, despite representing 13% and 18% of the US population. This underrepresentation can limit the generalizability of the results and exclude underrepresented populations from accessing life-saving treatments and therapies.

Tury Health aims to address this issue by leveraging advanced AI algorithms and blockchain technology to automate and streamline the clinical trial recruitment process. Our decentralized clinical trial platform enables clinical trial sponsors to efficiently and cost-effectively recruit a diverse range of participants from anywhere in the world. By enrolling 50% of the study population as diverse individuals, Tury Health is taking a proactive step towards increasing the inclusivity and diversity of clinical trials.

In addition to increasing inclusivity and diversity, Tury Health's technology ecosystem also serves as a valuable resource for clinical trial sponsors and pharmaceutical companies seeking to improve the efficiency and effectiveness of their operations. By leveraging AI-powered solutions that automate administrative tasks and streamline healthcare workflows, Tury Health's technology can help these organizations focus on delivering patient-centered care and addressing the unique needs of diverse patient populations.

Furthermore, Tury Health's virtual lab solution can help clinical trial sponsors reduce the cost and time associated with traditional clinical trials. By enabling clinical trial participants to provide data and samples remotely, Tury Health can help reduce the need for participants to travel to a clinical trial site, which can be especially challenging for individuals with mobility issues or transportation barriers.

Another key target customer for Tury Health is digital health startups seeking to validate their products using rigorous and regulatory-grade scientific research. Tury Health's technology ecosystem can provide these startups with a reliable and efficient way to conduct clinical trials and validate the effectiveness of their products. By leveraging advanced AI and blockchain technology, Tury Health can help these startups streamline the clinical trial process, reduce costs, and accelerate the time to market for their products.

In conclusion, Tury Health's solution serves a diverse range of stakeholders within the healthcare industry, including clinical trial sponsors, pharmaceutical companies, medical device companies, and digital health startups. By leveraging advanced AI and blockchain technology, Tury Health is working to increase the inclusivity and diversity of clinical trials, improve the efficiency and effectiveness of clinical trial operations, and provide a valuable resource for digital health startups seeking to validate their products.

The Tury Health team is well-positioned to deliver our solution to the target population because of our extensive experience and expertise in the healthcare industry, as well as our commitment to diversity, equity, and inclusion.

Our team is comprised of experienced professionals with backgrounds and years of experience in healthcare, clinical research, AI, blockchain, and entrepreneurship. We have a deep understanding of the challenges and opportunities facing the healthcare industry and are passionate about using technology to improve the lives of patients and healthcare providers. 

Dr Kalesan is a trained clinical trialist, who has conducted trials across 19 countries in academia and industry. Dr. Paker, the Chief Scientific Officer is a highly experienced clinical development professional with over 20 years of experience in the pharmaceutical and biotech industry. Dr. Parker has a proven track record of success in designing and executing clinical development programs that resulted in the successful registration of several drugs. Ms. Khera, our advisor is a highly respected regulatory affairs professional with over 20 years of experience in the pharmaceutical and biotech industry. She is the Vice President of Regulatory Affairs at Worldwide Clinical Trials, a leading global contract research organization (CRO), with extensive experience working with regulatory agencies in the United States, Europe, and Asia.

In addition to our professional expertise, our team is also representative of the communities we are serving. As a diverse and inclusive team, we are committed to increasing the inclusivity and diversity of clinical trials and ensuring that underrepresented populations have access to life-saving treatments and therapies.

To understand the needs of the communities we are serving, we have engaged in extensive research and community outreach. We have consulted with patient advocacy groups, healthcare providers, and other stakeholders to gain a deeper understanding of the challenges and opportunities facing underrepresented populations in clinical trials. This research has informed the design and implementation of our solution, ensuring that it is meaningfully guided by the input, ideas, and agendas of the communities we are serving.

Furthermore, our decentralized clinical trial platform is designed to be highly customizable and adaptable to the needs of different patient populations. Our platform allows clinical trial sponsors to tailor the recruitment process to the needs and preferences of different patient populations, ensuring that the recruitment process is inclusive, accessible, and culturally sensitive.

In addition to our focus on diversity, equity, and inclusion, our team is also committed to ensuring that our solution is highly effective and efficient. We have leveraged advanced AI algorithms and blockchain technology to automate and streamline the clinical trial recruitment process, reduce costs, and accelerate the time to market for life-saving treatments and therapies.

Overall, the Tury Health team is well-positioned to deliver our solution to the target population. Our extensive experience and expertise in the healthcare industry, combined with our commitment to diversity, equity, and inclusion, have enabled us to design and implement a highly effective and efficient solution that meets the needs of patients, healthcare providers, and clinical trial sponsors.

Tury Health's solution is a prototype because we have a complete technology ecosystem in place that includes patient recruitment, a decentralized clinical trial platform, remote patient monitoring, virtual labs, and more. Our decentralized clinical trial platform has been tested in pilot studies, and we are currently scaling our solution to meet the needs of a broader range of clinical trial sponsors and patients.

Our advanced AI and blockchain technology automate and streamline the clinical trial recruitment process, making it more efficient and cost-effective for clinical trial sponsors. Our virtual lab solution allows clinical trial participants to provide data and samples remotely, which reduces the need for them to travel to a clinical trial site, making clinical trials more accessible to participants.

Our complete technology ecosystem provides a seamless end-to-end solution for clinical trial sponsors, from patient recruitment to remote monitoring to data analysis. This makes our solution more efficient, cost-effective, and convenient for clinical trial sponsors and patients alike.

We are also in the process of integrating our technology ecosystem with Salesforce Health Cloud, which will provide clinical trial sponsors with real-time insights into patient data. This will enable them to make more informed decisions and accelerate the drug development process.

Overall, Tury Health's solution is a prototype because we have a complete technology ecosystem in place that has been tested and is being scaled to meet the needs of a broader range of stakeholders in the healthcare industry. Our solution is more efficient, cost-effective, and convenient for clinical trial sponsors and patients alike. Our integration with Salesforce Health Cloud will further enhance the value we provide to clinical trial sponsors by enabling real-time insights into patient data.

As a pre-revenue startup, Tury Health is not currently serving any customers. However, we are actively developing and testing our solution, and we are in discussions with several potential clinical trial sponsors and digital health startups who are interested in using our platform to conduct decentralized clinical trials.

Once we launch our platform, we expect to serve a significant number of clinical trial sponsors and patients. Our solution is designed to be scalable, and we believe that our platform has the potential to transform the clinical trial industry by increasing the inclusivity and diversity of clinical trials and making them more efficient and cost-effective.

Overall, while we are not currently serving any customers, we believe that our solution has the potential to serve a significant number of clinical trial sponsors and patients once we launch our platform.

Tury Health is applying to Solve because we believe that their mission to support innovative solutions to global challenges aligns perfectly with our mission to transform the clinical trial industry through the use of decentralized clinical trial platforms that increase inclusivity and diversity, and make clinical trials more efficient and cost-effective.

As a pre-revenue startup, we face several financial and technical barriers that we hope Solve can help us overcome. Specifically, we are seeking mentorship and guidance from experts in the healthcare and tech industries to help us develop our solution further, navigate the complex regulatory landscape, and identify potential partners and customers.

We are also looking to connect with potential investors and partners who share our vision for transforming the clinical trial industry. We believe that Solve can help us connect with potential partners who can provide the financial, technical, legal, and cultural support we need to bring our solution to market and make a meaningful impact on the healthcare industry.

We are not solely looking to raise funds, but also seeking to connect with potential partners who can provide non-monetary support such as mentorship, guidance, and connections to industry experts.

Overall, we are excited about the opportunity to apply to Solve and believe that their platform can provide us with the support we need to overcome the financial, technical, legal, cultural, and market barriers we face as a pre-revenue startup. We are eager to work with Solve to advance our solution and make a meaningful impact on the healthcare industry.

Tury Health's solution is innovative in several ways. We use advanced AI and blockchain technology to automate and streamline the clinical trial recruitment process, making it more efficient and cost-effective for clinical trial sponsors. Our virtual lab solution also allows clinical trial participants to provide data and samples remotely, reducing the need for them to travel to a clinical trial site and making clinical trials more accessible.

We are committed to increasing the inclusivity and diversity of clinical trials by enrolling at least 50% of our study populations from diverse communities that are often underrepresented in clinical trials. This can help reduce healthcare disparities and ensure that clinical trial results are representative of the broader population.

Our solution is also unique in its integration with Salesforce Health Cloud, which provides clinical trial sponsors with real-time insights into patient data. This enables them to make more informed decisions and accelerate the drug development process.

Overall, we believe that our solution has the potential to catalyze broader positive impacts in the healthcare industry. By increasing inclusivity and diversity in clinical trials, our solution can help reduce healthcare disparities and improve the representation of the broader population. Our use of advanced technology can make clinical trials more accessible and cost-effective, leading to an increase in the number of clinical trials conducted and acceleration of the drug development process. Additionally, our integration with Salesforce Health Cloud can help clinical trial sponsors make more informed decisions and speed up the drug development process.

Our solution has the potential to change the market by providing a complete technology ecosystem that streamlines the clinical trial process, makes it more accessible, and is more representative of diverse communities. By offering a more efficient, cost-effective, and inclusive solution, we believe that we can disrupt the traditional clinical trial industry and drive positive change in the healthcare sector.

In summary, Tury Health's innovative solution uses advanced AI and blockchain technology to streamline the clinical trial recruitment process and improve inclusivity and diversity. Our integration with Salesforce Health Cloud provides real-time insights into patient data, accelerating the drug development process. Our solution has the potential to catalyze broader positive impacts in the healthcare industry, change the market, and drive positive change in the healthcare sector.

Tury Health's impact goals for the next year and the next five years are centered around increasing inclusivity and diversity in clinical trials, accelerating the drug development process, and ultimately improving healthcare outcomes for all individuals.

In the next year, we aim to start our first trial and enroll participants that use our technology ecosystem, with a goal of enrolling at least 50% of participants from diverse communities that are often underrepresented in clinical trials. We will achieve this by partnering with digital health startups and pharmaceutical companies that share our commitment to increasing inclusivity and diversity in clinical trials. We will also continue to improve our technology ecosystem to streamline the clinical trial recruitment process and make it more accessible for all individuals.

Over the next five years, our impact goals expand to include a goal of enrolling at least 10,000 participants in clinical trials that use our technology ecosystem, with at least 50% of participants coming from diverse communities. We also aim to partner with more pharmaceutical companies and clinical trial sponsors to increase the adoption of our technology ecosystem and accelerate the drug development process. Additionally, we will work to expand our platform's capabilities, including the integration of wearable devices and other health monitoring technologies, to improve the accuracy and depth of patient data.

To achieve these impact goals, we plan to continue our partnerships with pharmaceutical companies and digital health startups to expand our reach and impact. We will also prioritize building relationships with patient advocacy groups and community organizations to better understand the needs of underrepresented communities and increase enrollment from these groups in clinical trials. Additionally, we plan to continue to develop our technology ecosystem, including the integration of Salesforce Health Cloud and other technologies, to make the clinical trial process more efficient and effective.

Ultimately, our impact goals are focused on improving healthcare outcomes for all individuals, including those from underrepresented communities. By increasing inclusivity and diversity in clinical trials and accelerating the drug development process, we believe that our solution can have a transformative impact on the healthcare industry.

Tury Health is committed to measuring our progress toward our impact goals with a set of key performance indicators (KPIs) that are closely aligned with the UN Sustainable Development Goals (SDGs). Our KPIs are designed to measure the success of our solution in increasing inclusivity and diversity in clinical trials, accelerating the drug development process, and improving healthcare outcomes for all individuals.

First and foremost, we are measuring the number of diverse participants enrolled in clinical trials using our technology ecosystem. We believe that by increasing inclusivity and diversity in clinical trials, we can improve healthcare outcomes for all individuals, regardless of their background or identity. This KPI aligns directly with SDG 3, which aims to ensure healthy lives and promote well-being for all at all ages.

We are also tracking the time it takes to recruit these participants using our technology ecosystem. This KPI is critical to improving the efficiency of the clinical trial recruitment process, which is a major barrier to accelerating the drug development process. By reducing the time it takes to recruit participants, we can help pharmaceutical companies and clinical trial sponsors get their products to market faster, ultimately improving healthcare outcomes for patients. This KPI aligns with SDG 9, which aims to build resilient infrastructure, promote sustainable industrialization, and foster innovation.

Another important KPI for us is the number of partnerships we have with pharmaceutical companies and digital health startups. We believe that partnerships are critical to expanding the reach and impact of our solution and increasing the adoption of our technology ecosystem. By partnering with companies that share our commitment to improving healthcare outcomes, we can work together to accelerate the drug development process and increase inclusivity in clinical trials. This KPI aligns with SDG 17, which aims to strengthen the means of implementation and revitalize the global partnership for sustainable development.

We are measuring the diversity of our team and board of directors. We believe that having a diverse team and board is critical to understanding and addressing the needs of underrepresented communities and increasing inclusivity in clinical trials. By prioritizing diversity in our hiring and leadership decisions, we can ensure that our solution is designed and implemented in a way that is sensitive to the needs of all individuals. This KPI aligns with SDG 5, which aims to achieve gender equality and empower all women and girls.

By tracking these KPIs, we can measure our progress toward our impact goals and continuously improve our solution to achieve maximum impact. We are committed to regularly reporting on these KPIs to our stakeholders and partners to ensure transparency and accountability in our work. Additionally, we will use these KPIs to inform our decision-making and ensure that we are prioritizing initiatives that have the greatest potential for impact. With a clear set of impact goals and KPIs to measure our progress, we are confident that Tury Health can make a transformative impact on the healthcare industry.

At Tury Health, our theory of change is centered on improving healthcare outcomes by increasing inclusivity and diversity in clinical trials. By leveraging advanced technology and innovative solutions, we can address the systemic barriers that prevent individuals from the benefits of clinical research. Our theory of change is guided by a clear logical framework, which links our activities to immediate outputs and longer-term outcomes for our target population.

Our first activity is to leverage our technology ecosystem to increase inclusivity and diversity in clinical trials. This includes using AI-powered patient recruitment tools to identify and engage with underrepresented populations, such as women, people of color, and individuals with disabilities. We will also leverage virtual lab technologies and remote patient monitoring tools to increase accessibility to clinical trials, particularly for individuals who live in remote or underserved areas. Our immediate output will be to enroll a more diverse study population, with the goal of having at least 50% of our participants be from diverse backgrounds.

Our second activity is to reduce the time it takes to recruit participants for clinical trials. By streamlining the recruitment process and leveraging advanced technologies such as machine learning algorithms, we can accelerate the drug development process. Our immediate output will be a reduction in the time it takes to recruit participants for clinical trials, which will ultimately lead to faster drug development and improved healthcare outcomes for patients.

Our third activity is to partner with pharmaceutical companies and digital health startups to expand the reach and impact of our solution. By collaborating with companies that share our commitment to increasing inclusivity and diversity in clinical trials, we can amplify our impact and reach a wider audience. Our immediate output will be the formation of strategic partnerships with key players in the healthcare industry.

These activities will lead to several longer-term outcomes. First, we expect that our solution will increase inclusivity and diversity in clinical trials, leading to improved healthcare outcomes for all individuals. Second, we expect that our solution will accelerate the drug development process, bringing life-saving treatments to market faster and improving healthcare outcomes for patients. Finally, we expect that our solution will catalyze broader positive impacts in the healthcare industry, inspiring other companies to prioritize inclusivity and diversity in their own clinical trials.

To support the existence and strength of these links, we have conducted extensive research and analysis, including a literature review of existing research on clinical trial diversity and a series of interviews with underrepresented communities to understand their needs and barriers to participation in clinical research. We plan to conduct ongoing process and impact evaluations to continuously monitor and improve our solution.

In summary, our theory of change is based on a clear logical framework that links our activities to immediate outputs and longer-term outcomes for our target population. By leveraging advanced technology and innovative solutions, we can make a transformative impact on the healthcare industry, increasing inclusivity and diversity in clinical trials and improving healthcare outcomes for all individuals.

At Tury Health, we are proud to offer a state-of-the-art decentralized clinical trial platform that leverages cutting-edge technology, including blockchain, to streamline the clinical trial process. Our platform allows for remote patient monitoring, virtual laboratory capabilities, and AI-powered patient recruitment tools that are all essential to improving healthcare outcomes for patients.

Blockchain technology is a key component of our decentralized clinical trial platform. It provides an immutable and transparent ledger that ensures the integrity and security of clinical trial data while protecting the privacy of study participants. By leveraging blockchain technology, we can create a tamper-proof, decentralized system that enables secure data management, efficient monitoring of clinical trials, and faster decision-making. This not only reduces the time and costs associated with clinical trials but also increases trust in the clinical trial process and the data generated from it.

Our decentralized clinical trial platform allows for a more flexible and efficient clinical trial process, reducing the burden on study participants and increasing the accessibility of clinical trials. The platform enables decentralized data sharing, secure data management, and efficient monitoring of clinical trials, allowing for faster decision-making and improved clinical outcomes.

In addition to our decentralized clinical trial platform, we also offer remote patient monitoring tools and virtual laboratory capabilities. Our remote patient monitoring tools enable continuous monitoring of study participants' vital signs, medication adherence, and other health-related data, allowing for real-time monitoring of clinical trial outcomes. Our virtual laboratory capabilities enable the collection of biosamples and other clinical data from participants, reducing the need for in-person visits and increasing the convenience for study participants.

Our AI-powered patient recruitment tool is another key component of our technology ecosystem. Our tool uses machine learning algorithms to analyze and identify potential participants based on their medical history, demographics, and other factors. By using targeted and personalized outreach campaigns, we can reach underrepresented populations such as women, people of color, and individuals with disabilities, who are often excluded from clinical trials. Our recruitment tool also allows for efficient screening and matching of participants to clinical trials, increasing the chances of finding suitable candidates and reducing the time and costs associated with recruitment.

Overall, our technology ecosystem is designed to improve the clinical trial process, increase the accessibility of clinical trials, and ultimately improve healthcare outcomes for patients. By leveraging state-of-the-art technology, including blockchain, we can reduce barriers to participation in clinical trials, increase diversity and inclusivity in clinical research, and ultimately lead to more effective and equitable healthcare for all.

We believe that our technology has the potential to catalyze broader positive impacts in the healthcare industry. By reducing the time and costs associated with clinical trials, our platform can accelerate the development of new treatments and therapies, improving healthcare outcomes for all individuals. Our focus on increasing diversity and inclusivity in clinical trials can also lead to better representation of diverse populations in healthcare research, ultimately leading to more effective and equitable healthcare for all.

In summary, our technology ecosystem, which includes a state-of-the-art decentralized clinical trial platform, remote patient monitoring tools, virtual laboratory capabilities, AI-powered patient recruitment tools, and blockchain technology, is at the forefront of innovation in the healthcare industry. By leveraging advanced technology, we are improving the clinical trial process, increasing diversity and inclusivity in clinical research, and ultimately improving healthcare outcomes for patients.

At Tury Health, we are committed to incorporating diversity, equity, and inclusivity into our work. We recognize that diversity is critical to innovation and achieving our mission of improving clinical research for all. Our team is made up of individuals from diverse backgrounds, including gender, ethnicity, race, and sexual orientation. We believe that having a diverse team allows us to approach problems from different perspectives and create more inclusive solutions.

We are also committed to increasing diversity and representation in clinical research. We have set a goal to enroll at least 50% of our study population from diverse communities. This means working to overcome the historical barriers that have prevented underrepresented populations from participating in clinical trials. We are actively engaging with communities to understand their concerns and needs and working to create more inclusive trial designs that reflect their experiences.

We recognize that achieving diversity and inclusivity requires ongoing effort and commitment. We are taking several steps to ensure that we create a welcoming and inclusive environment for our team and the communities we serve. These steps include:

1. Diversity and Inclusion Training: We are committed to providing our team with the tools and resources they need to create an inclusive environment. We are investing in diversity and inclusion training for our team to help us better understand and address issues related to bias, equity, and inclusion.

2. Community Engagement: We believe that engaging with communities is critical to achieving diversity and inclusivity. We are actively engaging with diverse communities to understand their needs and concerns and working to create more inclusive clinical trial designs.

3. Hiring Practices: We are committed to creating a diverse and inclusive team. We are reviewing our hiring practices to ensure that we are attracting a diverse pool of candidates and providing equal opportunities for all.

4. Partnering with Diverse Organizations: We are committed to partnering with diverse organizations to expand our reach and impact. We are actively seeking out partnerships with organizations that share our commitment to diversity and inclusivity.

In summary, diversity, equity, and inclusivity are core values at Tury Health. We recognize that achieving these values requires ongoing effort and commitment. We are committed to creating an inclusive environment for our team and working to increase diversity and representation in clinical research. By doing so, we believe that we can create more equitable and impactful solutions that benefit everyone.

Tury Health's business model revolves around offering decentralized clinical trial solutions to pharmaceutical companies, medical device companies, digital health startups, and clinical trial sponsors. Our solution utilizes cutting-edge technology to improve the efficiency and inclusivity of clinical trials, thereby accelerating drug development and reducing costs.

Our primary source of revenue is through the sale of our services to clinical trial sponsors. We offer a range of services, including patient recruitment, remote patient monitoring, virtual laboratory services, and access to our decentralized clinical trial platform. By providing a comprehensive suite of services, we are able to streamline the clinical trial process and reduce the time and resources required for drug development.

Our platform is designed to be scalable and customizable to meet the needs of a variety of clinical trial sponsors. We offer flexible pricing plans to ensure that our solutions are accessible to companies of all sizes, from early-stage startups to large pharmaceutical corporations.

In addition to our primary revenue stream, we also plan to explore additional revenue opportunities through partnerships and collaborations. For example, we may partner with pharmaceutical companies to co-develop and co-market new drugs, or we may collaborate with academic institutions to conduct research studies using our platform.

We believe that our business model has the potential to significantly disrupt the clinical trial industry by making trials more accessible, efficient, and cost-effective. By leveraging innovative technology and a customer-centric approach, we are able to offer solutions that meet the needs of a diverse range of clinical trial sponsors.

Our ultimate goal is to drive a positive impact on patients and communities by accelerating the drug development process and improving the accessibility of clinical trials. By partnering with clinical trial sponsors and leveraging cutting-edge technology, we are confident that we can achieve this goal while building a sustainable and profitable business model.

Tury Health's revenue model is based on three main sources: clinical trial sponsors, digital health startups, and pharmaceutical and medical device companies. We plan to generate revenue by providing end-to-end clinical trial services to our clients.

Our primary customer base will be clinical trial sponsors who are looking to increase the diversity of their study populations while still maintaining regulatory compliance. We plan to provide a decentralized clinical trial platform that integrates patient enrollment, remote patient monitoring, and virtual laboratory capabilities. We will charge clinical trial sponsors a fee for accessing our platform and services, which will vary depending on the scope and size of the study.

In addition to clinical trial sponsors, we also plan to target digital health startups looking to validate their products using rigorous and regulatory-grade scientific research. Our platform will provide these startups with access to a diverse population of patients and an efficient way to conduct clinical trials. We will charge digital health startups a fee for using our platform and services.

Finally, we will target pharmaceutical and medical device companies. These companies are increasingly focused on reducing the time and cost of clinical trials while still maintaining regulatory compliance. Our platform will provide these companies with access to a diverse population of patients and an efficient way to conduct clinical trials. We will charge pharmaceutical and medical device companies a fee for using our platform and services.

In order to become financially sustainable, we plan to scale our platform and services to serve a larger customer base while maintaining high-quality standards. We will leverage partnerships and collaborations to expand our reach and increase our revenue streams. Our team has experience in fundraising and we plan to raise capital through equity funding rounds to support our growth and expansion.

In addition to generating revenue from our platform and services, we also plan to explore other potential revenue streams. For example, we may consider selling de-identified patient data to pharmaceutical and medical device companies for research purposes.

Our focus on diversity, equity, and inclusion is a key differentiator and we believe it will also help us attract and retain customers. By focusing on recruiting and enrolling diverse study populations, we can help our customers meet their regulatory requirements while also contributing to a more equitable healthcare system. This commitment to diversity and inclusion will help us build long-term relationships with our customers and establish ourselves as a leader in the decentralized clinical trial space.

In summary, Tury Health's revenue model is based on providing end-to-end clinical trial services to our customers, including clinical trial sponsors, digital health startups, and pharmaceutical and medical device companies. We plan to generate revenue by charging a fee for accessing our platform and services. We will also explore other potential revenue streams, such as selling de-identified patient data. Our focus on diversity, equity, and inclusion will help us attract and retain customers and establish ourselves as a leader in the decentralized clinical trial space.

Tury Health's financial sustainability plan has already shown promising success, and we have ambitious plans to further build on this success.

One major milestone in our funding journey was being selected for the National Science Foundation (NSF) seed fund program, which provides funding to startups with high potential for commercialization and societal impact. We are currently in the process of submitting a full grant application to the NSF, and we are optimistic about the potential for securing further funding through this program.

In addition to the NSF seed fund, we have also received interest from several potential investors who see the immense potential of our decentralized clinical trial platform. We are in ongoing talks with these investors and exploring potential funding opportunities that align with our mission and values.

Another exciting development for Tury Health was our recent acceptance into the Founder Institute accelerator program. As a graduate of this prestigious program, we will have access to a wide range of resources, mentorship opportunities, and networking events that will help us accelerate our growth and achieve our financial sustainability goals.

We are also actively seeking partnerships with other companies and organizations that share our commitment to innovation and improving healthcare outcomes. For example, we are currently in discussions with Neural Technology, a leading provider of AI-powered clinical trial solutions, to explore potential collaboration opportunities.

Another key aspect of our financial sustainability plan is our focus on revenue-generating services. We plan to offer a range of services to our clients, including patient recruitment, remote patient monitoring, virtual laboratory services, and other value-added services. By diversifying our revenue streams and building a strong client base, we can ensure long-term financial sustainability while also achieving our mission of making clinical trials more accessible and inclusive.

Finally, we believe that our ongoing commitment to innovation and staying on the cutting edge of emerging technologies and trends in the digital health space will be key to our financial sustainability. We are constantly exploring new technologies and working with digital health companies to identify potential opportunities for collaboration and growth.

Overall, we are confident that our financial sustainability plan is sound and that we have the right team, partnerships, and services in place to achieve our goals. We will continue to explore new opportunities and build on our success as we work to make decentralized clinical trials a reality for people around the world.